Ken Keller Email & Phone Number
@dsi.com
4 phones found area 973 and 908
LinkedIn matched
Who is Ken Keller? Overview
A concise factual answer block for searchers comparing this professional profile.
Ken Keller is listed as CEO Council Member at WSJ CEO Council, a with 12318 employees, based in Basking Ridge, New Jersey, United States. AeroLeads shows a work email signal at dsi.com, phone signal with area code 973, 908, and a matched LinkedIn profile for Ken Keller.
Ken Keller previously worked as Chairman of the Board, President and CEO and Head of the Global Oncology Business Unit at Daiichi Sankyo, Inc. and President and CEO at American Regent, Inc.. Ken Keller holds Master Of Business Administration (M.B.A.), Business Administration And Management, General from Loyola Marymount University.
Email format at WSJ CEO Council
This section adds company-level context without repeating Ken Keller's masked contact details.
AeroLeads found 1 current-domain work email signal for Ken Keller. Compare company email patterns before reaching out.
About Ken Keller
Serving as Chairman of the Board, President and CEO of Daiichi Sankyo, Inc. and Global Head of the Daiichi Sankyo Oncology Business is the privilege of a lifetime. At Daiichi Sankyo, we create essential medicine for longer, better lives. Every day, we strive to put our skills at the service of those in need. We unite cutting edge science and technology with unwavering dedication and care to develop life-changing solutions for our patients. I’m honored to help lead thousands of teammates around the world dedicated to our vision of creating life-changing solutions for the patients of today and tomorrow. Compassion for patients is in our DNA and fuels our efforts to develop innovative medicines that can change the standard of care for people impacted by cancer.
Listed skills include Oncology, Strategy, Pharmaceutical Industry, Managed Care, and 8 others.
Ken Keller's current company
Company context helps verify the profile and gives searchers a useful next step.
Ken Keller work experience
A career timeline built from the work history available for this profile.
Ceo Council Member
Current
Chairman Of The Board, President And Ceo And Head Of The Global Oncology Business Unit
Current
President And Ceo
Ken is responsible for leading both Daiichi Sankyo Inc. and American Regent Inc. American Regent is a Daiichi Sankyo Group company that develops, manufactures and commercializes over 80 products through three divisions: American Regent , Animal Health and Osteohealth. Revenue exceeds $1.5Billion with a total employee base of approximately 1000, including four US based manufacturing operations .
Executive Vice President And Chief Operating Officer
Prior to his current role at Daiichi-Sankyo , Mr. Keller was the Chief Operating Officer at Spectrum Pharmaceuticals, where he held global responsibility for leading commercial operations, medical and clinical development, regulatory, quality, safety and pharmaceutical operations. Under his leadership, Spectrum's portfolio grew from two to four marketed products, acquired two advanced stage products and achieved sustainable profitability. Ken was responsible for the integration of both Allos Therapeutics Inc. and Talon Therapeutics Inc., following their acquisitions.
Vice President And General Manager , Bone Health
Mr. Keller spent 22 years at Amgen. His most recent role was Vice President and General Manager, Bone Health Business Unit. Previous to this role, he was responsible for the Inflammation Business Unit , as VP and General Manager, which contributed more than $3 billion in revenue. During his career at Amgen, Mr. Keller was the marketing lead or the general manager for five of the world's top selling biologic medicines Neupogen®, Neulasta®, Aranesp® ,Enbrel® and Prolia®.. He also has significant international experience as managing director for Amgen's United Kingdom and Ireland Affiliate, where he lead the affiliate to significant top line and bottom line growth .Ken started his career at Beecham Pharmacueticals as a Sales Representative
Vice President And General Manager, Inflammation
Responsible for Leading a $3B highly competitive business. Delivered consistent revenue growth , while effectively reducing operating expenses.
Managing Director United Kingdom And Ireland
As managing director held responsibility for the overall leadership , including P&L , medical affairs, HR and sales and marketing. Total revenue grew 50% in this time period and operating profitability increased over 200%.
Vice President , Oncology
Responsible for leading the marketing for Amgen's Oncology Portfolio , including the launch of Neulasta and Aranesp. Both products became highly successful , generating revenue of over four Billion dollars per year , changing the practice of oncology and delivering multi billion dollars of profit for the organization. Led the market strategy and launch for Vectibex , Amgen’s first in Oncology therapeutic.
Multiple Roles From Sales Representative, Sales Manager, Marketing Director Etc.
Ken started as a Sales Representative and held numerous roles of increasing responsibility in both sales , sales leadership , marketing and Global Product Management. Delivering outstanding results in therapuetic areas of Oncology,Inflammation, and Nephrology. Ken started his career at Beecham Pharmacueticals as a Sales Representative
Colleagues at WSJ CEO Council
Other employees you can reach at wsj.com. View company contacts for 12318 employees →
Melika Rajabi
Colleague at Wsj Ceo CouncilNew York, United States
View →
SA
Sinta Ayu Lutfitasari
Colleague at Wsj Ceo CouncilSurabaya, East Java, Indonesia
View →
TM
Thomas Müller
Colleague at Wsj Ceo CouncilBern, Berne, Switzerland
View →
MA
Mubashar Ashraf
Colleague at Wsj Ceo CouncilSāhīwāl, Punjab, Pakistan
View →
JZ
Joško Zorić
Colleague at Wsj Ceo CouncilVelika Gorica, Zagreb, Croatia
View →
KU
Kshitij Upadhyay
Colleague at Wsj Ceo CouncilDelhi, India
View →
AA
Abdelmalk Allali
Colleague at Wsj Ceo CouncilAlgeria
View →
GL
Gy Ly
Colleague at Wsj Ceo CouncilUnited Arab Emirates
View →
AC
Alexandra Citrin-Safadi
Colleague at Wsj Ceo CouncilBrooklyn, New York, United States
View →
MS
Mustafa Saedi
Colleague at Wsj Ceo CouncilKabul, Kabul Province, Afghanistan
View →
Ken Keller education
Master Of Business Administration (M.B.A.), Business Administration And Management, General
Bachelors Of Science, Business
Frequently asked questions about Ken Keller
Quick answers generated from the profile data available on this page.
What company does Ken Keller work for?
Ken Keller works for WSJ CEO Council.
What is Ken Keller's role at WSJ CEO Council?
Ken Keller is listed as CEO Council Member at WSJ CEO Council.
What is Ken Keller's email address?
AeroLeads has found 1 work email signal at @dsi.com for Ken Keller at WSJ CEO Council.
What is Ken Keller's phone number?
AeroLeads has found 4 phone signal(s) with area code 973, 908 for Ken Keller at WSJ CEO Council.
Where is Ken Keller based?
Ken Keller is based in Basking Ridge, New Jersey, United States while working with WSJ CEO Council.
What companies has Ken Keller worked for?
Ken Keller has worked for Wsj Ceo Council, Daiichi Sankyo, Inc., American Regent, Inc., Spectrum Pharmaceuticals, Inc., and Amgen.
Who are Ken Keller's colleagues at WSJ CEO Council?
Ken Keller's colleagues at WSJ CEO Council include Melika Rajabi, Sinta Ayu Lutfitasari, Thomas Müller, Mubashar Ashraf, and Joško Zorić.
How can I contact Ken Keller?
You can use AeroLeads to view verified contact signals for Ken Keller at WSJ CEO Council, including work email, phone, and LinkedIn data when available.
What schools did Ken Keller attend?
Ken Keller holds Master Of Business Administration (M.B.A.), Business Administration And Management, General from Loyola Marymount University.
What skills is Ken Keller known for?
Ken Keller is listed with skills including Oncology, Strategy, Pharmaceutical Industry, Managed Care, Management, Clinical Development, Leadership, and Marketing.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial